The fastest-growing and largest of the 20 sized Healthcare Services markets in APAC, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Patient Support Programs (PSP) | $3.6 Bn | $12.7 Bn | 17.1% | 216 |
| 2 | Bioinformatics | $2.6 Bn | $11 Bn | 15.7% | 32 |
| 3 | Brain Cancer Diagnostic | $315 Mn | $1.3 Bn | 14.9% | 373 |
| 4 | Medical Tourism | $15.6 Bn | $55.1 Bn | 13.5% | 3 |
| 5 | Medical Billing | $945 Mn | $3.1 Bn | 12.7% | 19 |
| 6 | Dermatology Diagnostic | $5.5 Bn | $17.7 Bn | 12.5% | 1,190 |
| 7 | Healthcare Electronic Data Interchange (EDI) | $840 Mn | $2.3 Bn | 10.7% | 10 |
| 8 | Point Of Care (PoC) Molecular Diagnostic | $3.9 Bn | $10.7 Bn | 10.6% | 89 |
| 9 | Nursing Education | $2.2 Bn | $5.3 Bn | 9.4% | 126 |
| 10 | Dental Imaging | $714 Mn | $1.7 Bn | 9.2% | 90 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Hospitals and Health Systems | $914.8 Bn | $1,777.9 Bn | 6.9% | 20,278 |
| 2 | Healthcare In Vitro Diagnostic | $17.5 Bn | $28.8 Bn | 5.1% | 55 |
| 3 | Medical Tourism | $15.6 Bn | $55.1 Bn | 13.5% | 3 |
| 4 | Ambulatory Surgery Center | $8.4 Bn | $17.1 Bn | 7.4% | 3,332 |
| 5 | Ambulance Service | $6.6 Bn | $14.7 Bn | 8.4% | 161 |
| 6 | Dermatology Diagnostic | $5.5 Bn | $17.7 Bn | 12.5% | 1,190 |
| 7 | Fertility Service | $4.4 Bn | $9 Bn | 7.4% | 72 |
| 8 | Point Of Care (PoC) Molecular Diagnostic | $3.9 Bn | $10.7 Bn | 10.6% | 89 |
| 9 | Patient Support Programs (PSP) | $3.6 Bn | $12.7 Bn | 17.1% | 216 |
| 10 | Bioinformatics | $2.6 Bn | $11 Bn | 15.7% | 32 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand.
Patient Support Programs (PSP) grows fastest, at 17.1% a year from 2023 to 2033, ahead of Bioinformatics (15.7%).
Hospitals and Health Systems is the largest, worth about $914.8 Bn in 2023 and $1,777.9 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.